IL127331A0 - Peptide-based vaccine for influenza - Google Patents

Peptide-based vaccine for influenza

Info

Publication number
IL127331A0
IL127331A0 IL12733198A IL12733198A IL127331A0 IL 127331 A0 IL127331 A0 IL 127331A0 IL 12733198 A IL12733198 A IL 12733198A IL 12733198 A IL12733198 A IL 12733198A IL 127331 A0 IL127331 A0 IL 127331A0
Authority
IL
Israel
Prior art keywords
epitopes
influenza
epitope
influenza virus
hla molecules
Prior art date
Application number
IL12733198A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL12733198A priority Critical patent/IL127331A0/xx
Publication of IL127331A0 publication Critical patent/IL127331A0/xx
Priority to EP99972929A priority patent/EP1135159A2/fr
Priority to DK10003160.8T priority patent/DK2204187T3/da
Priority to AT10003160T priority patent/ATE556719T1/de
Priority to PT10003160T priority patent/PT2204187E/pt
Priority to KR1020017006639A priority patent/KR100703571B1/ko
Priority to NZ511918A priority patent/NZ511918A/en
Priority to EP10003160A priority patent/EP2204187B1/fr
Priority to CA2352454A priority patent/CA2352454C/fr
Priority to JP2000584919A priority patent/JP2002531415A/ja
Priority to BR9915811-6A priority patent/BR9915811A/pt
Priority to PCT/IL1999/000640 priority patent/WO2000032228A2/fr
Priority to IL14336799A priority patent/IL143367A0/xx
Priority to ES10003160T priority patent/ES2389611T3/es
Priority to US09/856,920 priority patent/US6740325B1/en
Priority to AU14066/00A priority patent/AU766883B2/en
Priority to IL143367A priority patent/IL143367A/en
Priority to HK02102105.6A priority patent/HK1040620A1/zh
Priority to US10/846,548 priority patent/US7192595B2/en
Priority to US11/672,429 priority patent/US7514086B2/en
Priority to HK10111907.7A priority patent/HK1145448A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL12733198A 1998-11-30 1998-11-30 Peptide-based vaccine for influenza IL127331A0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IL12733198A IL127331A0 (en) 1998-11-30 1998-11-30 Peptide-based vaccine for influenza
AU14066/00A AU766883B2 (en) 1998-11-30 1999-11-28 Peptide-based vaccine for influenza
CA2352454A CA2352454C (fr) 1998-11-30 1999-11-28 Vaccin a base de peptides contre la grippe
BR9915811-6A BR9915811A (pt) 1998-11-30 1999-11-28 Vacina a base de peptìdeo para influenza
AT10003160T ATE556719T1 (de) 1998-11-30 1999-11-28 Impfstoff gegen menschliche influenza, der vier peptide aus influenza enthält
PT10003160T PT2204187E (pt) 1998-11-30 1999-11-28 Vacina contra a gripe humana contendo quatro péptidos de influenza
KR1020017006639A KR100703571B1 (ko) 1998-11-30 1999-11-28 인플루엔자에 대한 펩티드-기초 백신
NZ511918A NZ511918A (en) 1998-11-30 1999-11-28 Flu vaccine comprising four synthetic peptide epitopes
EP10003160A EP2204187B1 (fr) 1998-11-30 1999-11-28 Vaccin contre la grippe humaine conténant quatre peptides d'influenza
EP99972929A EP1135159A2 (fr) 1998-11-30 1999-11-28 Vaccin a base de peptides contre la grippe
JP2000584919A JP2002531415A (ja) 1998-11-30 1999-11-28 ペプチドベースのインフルエンザ用ワクチン
DK10003160.8T DK2204187T3 (da) 1998-11-30 1999-11-28 Human influenzavaccine indeholdende fire influenzapeptider
PCT/IL1999/000640 WO2000032228A2 (fr) 1998-11-30 1999-11-28 Vaccin a base de peptides contre la grippe
IL14336799A IL143367A0 (en) 1998-11-30 1999-11-28 Peptide based vaccine for influenza
ES10003160T ES2389611T3 (es) 1998-11-30 1999-11-28 Vacuna contra la gripe humana que contiene cuatro péptidos de influenza
US09/856,920 US6740325B1 (en) 1998-11-30 1999-11-28 Peptide-based vaccine for influenza
IL143367A IL143367A (en) 1998-11-30 2001-05-24 Influenza vaccine based on peptides
HK02102105.6A HK1040620A1 (zh) 1998-11-30 2002-03-19 治療流感的肽基疫苗
US10/846,548 US7192595B2 (en) 1998-11-30 2004-05-17 Peptide-based vaccine for influenza
US11/672,429 US7514086B2 (en) 1998-11-30 2007-02-07 Peptide-based vaccine for influenza
HK10111907.7A HK1145448A1 (en) 1998-11-30 2010-12-21 Human flu vaccine containing four influenza peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12733198A IL127331A0 (en) 1998-11-30 1998-11-30 Peptide-based vaccine for influenza

Publications (1)

Publication Number Publication Date
IL127331A0 true IL127331A0 (en) 1999-09-22

Family

ID=11072200

Family Applications (3)

Application Number Title Priority Date Filing Date
IL12733198A IL127331A0 (en) 1998-11-30 1998-11-30 Peptide-based vaccine for influenza
IL14336799A IL143367A0 (en) 1998-11-30 1999-11-28 Peptide based vaccine for influenza
IL143367A IL143367A (en) 1998-11-30 2001-05-24 Influenza vaccine based on peptides

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL14336799A IL143367A0 (en) 1998-11-30 1999-11-28 Peptide based vaccine for influenza
IL143367A IL143367A (en) 1998-11-30 2001-05-24 Influenza vaccine based on peptides

Country Status (15)

Country Link
US (3) US6740325B1 (fr)
EP (2) EP1135159A2 (fr)
JP (1) JP2002531415A (fr)
KR (1) KR100703571B1 (fr)
AT (1) ATE556719T1 (fr)
AU (1) AU766883B2 (fr)
BR (1) BR9915811A (fr)
CA (1) CA2352454C (fr)
DK (1) DK2204187T3 (fr)
ES (1) ES2389611T3 (fr)
HK (2) HK1040620A1 (fr)
IL (3) IL127331A0 (fr)
NZ (1) NZ511918A (fr)
PT (1) PT2204187E (fr)
WO (1) WO2000032228A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127331A0 (en) * 1998-11-30 1999-09-22 Yeda Res & Dev Peptide-based vaccine for influenza
AU2002223398A1 (en) * 2000-08-10 2002-04-08 Tsinghua University A vaccine for influenza virus and its preparation
FI20031536A0 (fi) * 2003-10-20 2003-10-20 Biotie Therapies Oyj Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen
ES2372633T3 (es) 2003-11-04 2012-01-25 The Administrators Of The Tulane Educational Fund Procedimiento de evitar condensación de virus: células inhibiendo la función de la región de iniciación de condensación en los virus arn que tienen proteínas de envoltura fusogénicas de membrana de clase i.
GB0716992D0 (en) * 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
WO2006074303A2 (fr) * 2005-01-05 2006-07-13 Philadelphia Health And Education Corporation Vehicules d'administration, substances bioactives et vaccins viraux
EP2374474A1 (fr) 2005-01-19 2011-10-12 Vaxinnate Corporation Compositions comprenant des motifs moléculaires associés à des agents pathogènes et des antigènes et leur utilisation pour stimuler la réponse immunitaire
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
CA2610667A1 (fr) * 2005-06-01 2006-12-07 Variation Biotechnologies Inc. Formulation peptidique de vaccin antigrippal
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
CA2627105A1 (fr) * 2005-10-26 2007-05-03 Protelix, Inc. Vaccin antigrippal constitue d'antigenes combinatoires
CA2628837C (fr) * 2005-11-07 2018-11-27 Sidney Kimmel Cancer Center Vaccin a base de proteine de fusion portant un ligand cd40
US7914797B2 (en) 2005-12-06 2011-03-29 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Influenza vaccine
EP1976559B3 (fr) * 2006-01-27 2020-02-19 Seqirus UK Limited Vaccins contre la grippe contenant des hémaglutinines et des protéines matricielles
GB0613977D0 (en) * 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
EP2476432B1 (fr) * 2006-03-07 2015-08-19 Vaxinnate Corporation Compositions incluant de l'hémagglutinine, procédés pour leur fabrication et leurs méthodes d'utilisation
US20080208486A1 (en) * 2006-03-23 2008-08-28 Jari Natunen Integrated System, Device and Use Thereof
US8222204B2 (en) 2006-05-03 2012-07-17 The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC Influenza inhibiting compositions and methods
WO2008002663A2 (fr) * 2006-06-28 2008-01-03 The Board Of Trustees Of The Leland Stanford Junior University Protéines chimères immunogènes
FI20060946A0 (fi) * 2006-10-26 2006-10-26 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
CA2680600A1 (fr) * 2007-03-12 2008-09-18 Antigen Express, Inc. Elimination de la proteine li impliquee dans des constructions li-arni en immunotherapie anticancereuse
AU2008281384C1 (en) 2007-08-02 2012-08-16 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
WO2009128951A2 (fr) 2008-04-18 2009-10-22 Vaxinnate Corporation Compositions de protéines du virus respiratoire syncytial et leurs méthodes d'utilisation
EP3023107A1 (fr) 2008-04-21 2016-05-25 Nanobio Corporation Vaccin contre la grippe à nanoémulsions
US20090297552A1 (en) * 2008-04-25 2009-12-03 Aderem Alan A Flagellin polypeptide vaccines
CN102084252B (zh) 2008-05-02 2017-03-22 罗切斯特大学 用于流感免疫应答测量的阵列检测器系统
WO2010144797A2 (fr) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Vaccins contre la grippe avec immunogénicité accrue et leurs utilisations
CA2803282C (fr) 2009-07-06 2018-05-01 David E. Anderson Procedes pour preparer des vesicules et formulations produites a partir de ces procedes
AU2010270722B2 (en) 2009-07-06 2015-06-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
EP2590674B1 (fr) 2010-07-06 2017-02-22 Variation Biotechnologies Inc. Compositions et méthodes pour traiter la grippe
US20130323280A1 (en) 2011-01-13 2013-12-05 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
MX359103B (es) 2011-01-13 2018-09-14 Variation Biotechnologies Inc Composiciones y sus usos en el tratamiento de infecciones virales.
CA2828068C (fr) 2011-02-22 2019-03-19 Biondvax Pharmaceuticals Ltd. Polypeptides multimeres multi-epitopes utilises dans des vaccins contre la grippe saisonniere et pandemique
EP2729169A1 (fr) 2011-07-06 2014-05-14 Nanobio Corporation Vaccin contre le virus syncytial respiratoire humain
WO2013028738A1 (fr) 2011-08-22 2013-02-28 Nanobio Corporation Vaccin contre le virus de l'herpès simplex sous forme de nanoémulsion
WO2013072768A2 (fr) 2011-11-18 2013-05-23 Variation Biotechnologies, Inc. Dérivés synthétiques de mpl et ses utilisations
WO2013104995A2 (fr) 2012-01-12 2013-07-18 Variation Biotechnologies, Inc. Compositions et méthodes de traitement d'infections virales
US20150079077A1 (en) 2012-01-27 2015-03-19 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
CA2840997A1 (fr) 2013-02-05 2014-08-05 Nitto Denko Corporation Composition de vaccin pour administration transdermique
CA2840937A1 (fr) 2013-02-05 2014-08-05 Nitto Denko Corporation Composition de vaccin pour administration transdermique
JP2014169275A (ja) 2013-02-05 2014-09-18 Nitto Denko Corp 粘膜投与用ワクチン組成物
RU2685933C2 (ru) 2013-02-05 2019-04-23 Нитто Денко Корпорейшн Композиция противораковой вакцины, содержащая пептид wt1, для трансдермального введения
RU2697443C2 (ru) 2013-02-05 2019-08-14 Нитто Денко Корпорейшн Препарат противораковой вакцины, содержащий пептид wt1, в форме ленты трансдермального введения
JP6512568B2 (ja) 2013-02-05 2019-05-15 日東電工株式会社 経皮投与用ｗｔ１ペプチド癌ワクチン組成物
CN103961702B (zh) 2013-02-05 2019-04-09 日东电工株式会社 粘膜给予用wt1肽癌症疫苗组合物
IN2014CH00386A (fr) * 2013-02-05 2015-04-03 Nitto Denko Corp
KR20140100422A (ko) 2013-02-05 2014-08-14 닛토덴코 가부시키가이샤 백신 조성물
US20140220058A1 (en) 2013-02-05 2014-08-07 Nitto Denko Corporation Vaccine composition for transdermal or mucosal administration
RU2531235C2 (ru) 2013-02-15 2014-10-20 Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") Поливалентная вакцина против гриппа на основе гибридного белка
CN103901202B (zh) * 2014-04-04 2015-08-12 中国人民解放军成都军区疾病预防控制中心 基于共有表位甲型流感病毒抗体通用型竞争性elisa检测方法
WO2016035809A1 (fr) 2014-09-03 2016-03-10 日東電工株式会社 Composition pharmaceutique vaccinale renfermant un bisphosphonate, destinée à induire l'immunité humorale
JP6577795B2 (ja) 2014-09-03 2019-09-18 日東電工株式会社 ビスホスホネート剤を含む細胞性免疫用ワクチン医薬組成物
US11278616B2 (en) 2015-08-06 2022-03-22 Nitto Denko Corporation Immunity induction promoting composition, and vaccine pharmaceutical composition
JP2020515283A (ja) 2016-12-28 2020-05-28 インブバックス，インコーポレーテッド インフルエンザワクチン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
IL101639A0 (en) * 1992-04-17 1992-12-30 Yeda Res & Dev Recombinant influenza vaccines
AU3036597A (en) * 1996-05-21 1997-12-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
IL127331A0 (en) * 1998-11-30 1999-09-22 Yeda Res & Dev Peptide-based vaccine for influenza

Also Published As

Publication number Publication date
AU766883B2 (en) 2003-10-23
US20050002954A1 (en) 2005-01-06
US20070122424A1 (en) 2007-05-31
WO2000032228A3 (fr) 2000-10-05
US7192595B2 (en) 2007-03-20
PT2204187E (pt) 2012-08-10
JP2002531415A (ja) 2002-09-24
BR9915811A (pt) 2001-08-21
AU1406600A (en) 2000-06-19
KR100703571B1 (ko) 2007-04-05
HK1145448A1 (en) 2011-04-21
DK2204187T3 (da) 2012-08-20
EP2204187A1 (fr) 2010-07-07
ES2389611T3 (es) 2012-10-29
US6740325B1 (en) 2004-05-25
KR20010089512A (ko) 2001-10-06
HK1040620A1 (zh) 2002-06-21
EP2204187B1 (fr) 2012-05-09
NZ511918A (en) 2003-08-29
IL143367A0 (en) 2002-04-21
CA2352454A1 (fr) 2000-06-08
ATE556719T1 (de) 2012-05-15
US7514086B2 (en) 2009-04-07
CA2352454C (fr) 2013-02-05
IL143367A (en) 2006-09-05
WO2000032228A2 (fr) 2000-06-08
EP1135159A2 (fr) 2001-09-26

Similar Documents

Publication Publication Date Title
IL127331A0 (en) Peptide-based vaccine for influenza
JP2002531415A5 (fr)
Liu et al. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity
Schild et al. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.
EE200000378A (et) Adamantaani derivaadid
ATE277633T1 (de) Präparate und verfahren zum auslösen von ctl- immunität
AR008765A1 (es) Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del
AU7791887A (en) Use of nucleocapsid protein VP6 in vaccine compositions
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
RS51602B (sr) April receptor (bcma) i njegova upotreba
BR0009580A (pt) Composição, processos para preparar vìrus da influenza, para preparar um veìculo de liberação de genes, para preparar vìrus da influenza defeituosos de replicação infecciosa, para imunizar um paciente contra um patógeno, para preparar vìrus infeccioso, e para preparar vìrus, vìrus, célula, vetor, célula hospedeira, e, uso do vìrus
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
ATE35152T1 (de) Plasmide und modifizierte staemme von vibrio cholerae, ihre herstellung und davon abgeleitete vakzine.
NO880494L (no) Syntetiske nonapeptid- og decapeptidanaloger av lhrh som er anvendelige som lhrh-antagonister.
BR9307029A (pt) Mecanismo de empacotamento de suporte de artigo do tipo clipe
NO180584C (no) Bisnaftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler, samt farmasöytiske preparater
BR9912176A (pt) Epìtopos de célula auxiliar t artificial como estimuladores imunes para imunógenos de peptìdeo sintéticos incluindo peptìdeos de lhrh imunogênicos
AU4622693A (en) Potentiation of immunogenic response
ATE326237T1 (de) Miscmicellen aus lipopeptiden für induzierung einer immunantwort
DE69620761D1 (de) Pharmazeutisches praeparat auf der basis eines diclofenac-salzes und der verbindung thiocolchicosid
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
ES2171086T3 (es) Uso de proteinas hmg para la preparacion de medicamentos con actividad citotoxica.
DE69527708D1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
DE69428984T2 (de) Stimulierung der immunantwort durch virales protein
BR9911388A (pt) Imunógeno de somatostatina sintético para promoção de crescimento em animais de fazenda